1. Home
  2. CNMD vs TNDM Comparison

CNMD vs TNDM Comparison

Compare CNMD & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

HOLD

Current Price

$43.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

HOLD

Current Price

$22.87

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNMD
TNDM
Founded
1970
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1987
2013

Fundamental Metrics

Financial Performance
Metric
CNMD
TNDM
Price
$43.35
$22.87
Analyst Decision
Hold
Buy
Analyst Count
6
16
Target Price
$53.67
$24.00
AVG Volume (30 Days)
588.6K
1.4M
Earning Date
01-28-2026
02-25-2026
Dividend Yield
1.84%
N/A
EPS Growth
N/A
N/A
EPS
2.05
N/A
Revenue
$1,347,470,000.00
$1,007,001,000.00
Revenue This Year
$6.81
$8.59
Revenue Next Year
$0.64
$10.19
P/E Ratio
$21.21
N/A
Revenue Growth
4.61
17.87
52 Week Low
$38.32
$9.98
52 Week High
$74.70
$38.28

Technical Indicators

Market Signals
Indicator
CNMD
TNDM
Relative Strength Index (RSI) 60.58 59.21
Support Level $40.15 $21.35
Resistance Level $41.62 $23.95
Average True Range (ATR) 1.32 0.87
MACD 0.50 -0.10
Stochastic Oscillator 82.48 55.02

Price Performance

Historical Comparison
CNMD
TNDM

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: